LEXYAL® MONOPHASIC ADVANCED
MEDICAL GRADE DERMAL FILLER
Concentration: 24mg/ml Cross-linked Hyaluronic Acid
Stabilization: BDDE Cross-linking (Residue < 2ppm)
PRIMARY INDICATION
Correction of mid-to-deep dermal depressions, nasolabial folds, and structural volumizing. Monophasic integration ensures zero gel-tissue dissociation.
Rheological Profile
Storage Modulus (G’): 350 Pa (High Structural Support)
Phase Angle (Δδ): 65° (Optimal Cohesivity)
Complex Viscosity (η*): 250 Pa·s
Extrusion Force: 18.5 N (Precision Control)
Clinical Metrics
• Longevity: 6–9 months sustained volume retention.
• WSRS Improvement: 82% reduction in fold depth at Month 6.
• Safety Profile: Endotoxin < 0.05 EU/ml (Ph. Eur. Grade).
• Patient GAIS: 97.3% very satisfied/satisfied rating.
Safety Standards
CE 2292 Certified Medical Device
Lidocaine HCl 0.3% for Patient Comfort
Double Sterilization: Steam + Aseptic Fill
Moisture Content: < 1% for Stability
Kit Composition
1 x 1.1ml Pre-filled Graduated
Ergonomic Luer Lock design for high-pressure stability.
2 x 27G Terumo Thin-wall
Optimized for high-viscosity gel flow.
Instruction for Use (IFU) & Traceability Labels
Compliant with MDR 2017/745 regulations.
Injection Protocol & Parameters
Asepsis
Chlorhexidine 2% preparation of target site.
Depth
Deep dermis or subcutaneous junction.
Technique
Retrograde linear threading or bolus.
Post-Op
Molding for symmetry & cold compress.
LEGAL COMPLIANCE: For professional use by licensed medical practitioners only. Content is for informational purposes and does not constitute medical advice. Lexyal® is a registered trademark. Storage: 2°C to 25°C. Avoid direct sunlight and freezing. Dispose of biohazardous waste in accordance with local clinical protocols.

Reviews
There are no reviews yet.